import { Link } from 'react-router-dom'
import styles from './BlogPost.module.css'
import NewsletterEmbed from '@/components/ui/NewsletterEmbed'

const META_TITLE = 'Functional Lab Testing for GLP-1 Users: Beyond A1C | Hunter\'s Holistic Health'
const META_DESC = 'Standard labs miss the markers that predict GLP-1 outcomes. Dr. Hunter, PharmD, CFNMP, explains fasting insulin, HOMA-IR, adiponectin, and the tests that matter.'

function MetaTags() {
  if (typeof document === 'undefined') return null
  document.title = META_TITLE

  function setMeta(name: string, content: string, prop?: boolean) {
    const attr = prop ? 'property' : 'name'
    let el = document.querySelector(`meta[${attr}="${name}"]`) as HTMLMetaElement | null
    if (!el) {
      el = document.createElement('meta')
      el.setAttribute(attr, name)
      document.head.appendChild(el)
    }
    el.content = content
  }

  setMeta('description', META_DESC)
  setMeta('og:title', META_TITLE, true)
  setMeta('og:description', META_DESC, true)
  setMeta('og:type', 'article', true)
  setMeta('og:url', 'https://www.huntersholistichealth.com/blog/functional-labs-glp1-what-to-test', true)
  setMeta('twitter:card', 'summary')
  setMeta('twitter:title', META_TITLE)
  setMeta('twitter:description', META_DESC)
  let canonical = document.querySelector('link[rel="canonical"]') as HTMLLinkElement | null
  if (!canonical) { canonical = document.createElement('link'); canonical.setAttribute('rel', 'canonical'); document.head.appendChild(canonical) }
  canonical.href = 'https://www.huntersholistichealth.com/blog/functional-labs-glp1-what-to-test'
  return null
}

export default function Glp1FunctionalLabs() {
  return (
    <div className={styles.page}>
      <MetaTags />

      <nav className={styles.nav}>
        <Link to="/" className={styles.navLogo}>Hunter's Holistic Health</Link>
        <Link to="/join" className={styles.navCta}>Join the Community</Link>
      </nav>

      <article className={styles.article}>
        <header className={styles.articleHeader}>
          <p className={styles.byline}>Dr. Shallanda Hunter, PharmD, CFNMP | Functional Medicine Educator</p>
          <h1 className={styles.h1}>The Labs Your Doctor Did Not Order: Functional Testing for GLP-1 Users</h1>
          <p className={styles.meta}>February 2026 · Reviewed June 2026 · 8 min read</p>
        </header>

        <div className={styles.body}>
          <h2>The problem with standard metabolic testing</h2>
          <p>The standard metabolic panel most primary care physicians order includes fasting glucose, A1C, a lipid panel, and basic metabolic markers. These tests are useful. They are not sufficient for understanding the metabolic picture of a GLP-1 user.</p>
          <p>Fasting glucose tells you the sugar level in your blood after an overnight fast. A1C tells you the average blood sugar over the past three months. What neither test tells you is <em>why</em> your blood sugar sits where it does, and specifically whether the underlying driver is insulin resistance, impaired insulin secretion, or both. That distinction shapes how well GLP-1 therapy is likely to work and what else your protocol needs to address.</p>

          <h2>Fasting insulin: the missing marker</h2>
          <p>Fasting insulin is not included in standard metabolic panels. It requires a separate order, and most primary care physicians do not order it routinely. That is a meaningful gap.</p>
          <p>Fasting insulin measures the insulin in your blood after an overnight fast. In a metabolically healthy person, fasting insulin generally runs on the lower end of the reference range. Many functional-medicine clinicians target an even lower optimal value, though these tighter cutoffs are practice conventions rather than universally established thresholds.</p>
          <p>Elevated fasting insulin with normal fasting glucose is a marker of insulin resistance: the body is producing more insulin than it should need to keep blood sugar normal. This compensatory hyperinsulinemia is often the earliest detectable sign of metabolic dysfunction, sometimes appearing years before glucose abnormalities show up on standard tests. For GLP-1 users, fasting insulin gives a baseline that lets you track insulin sensitivity over time, which is a more sensitive marker than glucose or A1C alone.</p>

          <h2>HOMA-IR: quantifying insulin resistance</h2>
          <p>HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a calculated value derived from fasting glucose and fasting insulin:</p>
          <p><strong>HOMA-IR = (Fasting Glucose in mg/dL &times; Fasting Insulin in &micro;IU/mL) &divide; 405</strong></p>
          <p>General interpretation ranges (these vary by population and lab, so use them as a guide, not a diagnosis):</p>
          <ul>
            <li>Below ~1.0: optimal insulin sensitivity</li>
            <li>~1.0 to 1.9: early insulin resistance</li>
            <li>~2.0 to 2.9: moderate insulin resistance</li>
            <li>Above ~3.0: significant insulin resistance</li>
          </ul>
          <p>HOMA-IR is not a standalone lab test; it is calculated from two values that must both be ordered. But it condenses insulin resistance into a single number that is trackable over time.</p>

          <h2>Adiponectin: the protective hormone</h2>
          <p>Adiponectin is an anti-inflammatory hormone produced by fat cells that improves insulin sensitivity and has cardiovascular-protective associations. Counterintuitively, adiponectin levels are <em>lower</em> in people with obesity and metabolic dysfunction, because the fat cells producing it are dysfunctional.</p>
          <p>As metabolic health improves through weight loss, exercise, and dietary change, adiponectin tends to rise, which makes it a useful marker for tracking metabolic improvement beyond the number on the scale. Low adiponectin is associated with increased cardiovascular risk, insulin resistance, and systemic inflammation.</p>

          <h2>High-sensitivity CRP: measuring inflammation</h2>
          <p>Chronic low-grade inflammation is both a cause and a consequence of metabolic dysfunction. High-sensitivity CRP (hsCRP) measures systemic inflammation and is a well-validated predictor of cardiovascular risk. For GLP-1 users, tracking hsCRP over time shows whether the metabolic intervention is reducing inflammatory burden, a sign of real metabolic improvement rather than weight loss alone.</p>
          <p>General interpretation: below 1.0 mg/L is low cardiovascular risk; above 3.0 mg/L indicates elevated risk. Because CRP rises with any acute infection or injury, one high reading should be rechecked rather than acted on immediately.</p>

          <h2>The advanced lipid panel</h2>
          <p>Standard lipid panels measure total cholesterol, LDL, HDL, and triglycerides. They do not measure LDL particle number or size, which add information about cardiovascular risk beyond LDL concentration alone.</p>
          <p>Small, dense LDL particles are more atherogenic than large, buoyant ones. Two people can share the same LDL cholesterol level but differ in risk depending on particle characteristics. An advanced lipid panel (such as an NMR LipoProfile) measures LDL particle number, small LDL concentration, HDL particle number, and the triglyceride-to-HDL ratio.</p>
          <p>The triglyceride-to-HDL ratio is especially useful as an in-office proxy: a ratio above roughly 3.0 is associated with insulin resistance and a small, dense LDL pattern.</p>

          <h2>How to get these tests</h2>
          <p>These tests are not exotic. They are available through standard commercial laboratories such as Quest and LabCorp and can be ordered by any physician. The obstacle is simply that most primary care visits do not include them by default.</p>
          <p>Options for obtaining functional labs:</p>
          <ol>
            <li>Ask your primary care physician to add fasting insulin and hsCRP to your next metabolic panel.</li>
            <li>Use a direct-to-consumer lab service to order your own tests where permitted in your state.</li>
            <li>Work with a clinician who routinely orders comprehensive metabolic panels.</li>
          </ol>
          <p>The goal is not to replace standard care. It is to add the markers that give you and your care team a fuller picture of your metabolic health, and a more precise way to track whether your GLP-1 protocol is working at the level that matters most.</p>

          <h2>Frequently asked questions</h2>
          <p><strong>What labs should I ask for on a GLP-1 medication?</strong><br />Beyond the standard glucose, A1C, and lipid panel, the highest-value additions are fasting insulin, HOMA-IR (calculated from fasting glucose and insulin), hsCRP, and an advanced lipid panel. Adiponectin is a useful optional add-on.</p>
          <p><strong>Why isn't fasting insulin part of a normal checkup?</strong><br />It is not included in the default metabolic panel and is not part of most primary-care ordering templates. You usually have to request it specifically.</p>
          <p><strong>What is a good HOMA-IR?</strong><br />A value below roughly 1.0 suggests good insulin sensitivity, while values above about 3.0 suggest significant insulin resistance. Ranges vary by lab and population, so interpret with your clinician.</p>
          <p><strong>Can these labs show progress that the scale doesn't?</strong><br />Yes. Fasting insulin, HOMA-IR, adiponectin, and hsCRP can improve as metabolic health improves, sometimes independent of weight, which is why they are useful for tracking whether your protocol is doing more than moving the scale.</p>

          <p>Related reading: <Link to="/blog/metabolic-health-beyond-weight-loss">Metabolic Health Is Not a Number on a Scale</Link> | <Link to="/blog/68-percent-glp1-weight-regain-how-to-beat-it">Why Most GLP-1 Users Regain Weight</Link> | <Link to="/blog/glp1-muscle-loss-what-nobody-tells-you">GLP-1 and Muscle Loss</Link></p>

          <div className={styles.freeResource}>
            <strong>Free resource:</strong>{' '}
            <a href="https://go.fliplink.me/view/HHHlabrequestsheet" target="_blank" rel="noopener noreferrer">Lab Request Reference Sheet</a>
            {' '}— a printable guide to the functional labs discussed above. Bring it to your next appointment.
          </div>
          <div className={styles.freeResource}>
            <strong>Free resource:</strong>{' '}
            <a href="https://go.fliplink.me/view/HHHProviderAppointmentScripts" target="_blank" rel="noopener noreferrer">Provider Appointment Scripts</a>
            {' '}— word-for-word prompts for asking your provider about these labs and getting the conversation started.
          </div>

          <hr className={styles.rule} />

          <NewsletterEmbed />

          <hr className={styles.rule} />

          <p className={styles.sig}><em>Dr. Shallanda Hunter, PharmD, CFNMP</em><br />Functional Medicine Educator, Founder of Hunter's Holistic Health<br /><a href="https://huntersholistichealth.com">huntersholistichealth.com</a></p>

          <div className={styles.sources}>
            <p><strong>References:</strong></p>
            <ol>
              <li>Matthews DR et al. Homeostasis model assessment: insulin resistance and beta-cell function. <em>Diabetologia.</em> 1985;28(7):412–419.</li>
              <li>Nunes EA et al. Systematic review and meta-analysis of protein intake to support muscle mass. <em>J Cachexia Sarcopenia Muscle.</em> 2022;13(2):795–810.</li>
              <li>Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. <em>Physiol Rev.</em> 2013;93(3):993–1017.</li>
            </ol>
          </div>

          <div className={styles.disclaimer}>
            <p>For educational purposes only. Not medical advice. Always work with your prescribing physician to interpret lab results and make clinical decisions. Individual results may vary.</p>
            <p>These statements have not been evaluated by the FDA. This is not intended to diagnose, treat, cure, or prevent any disease.</p>
          </div>
        </div>
      </article>
    </div>
  )
}
